Afatinib Dimaleate Intermediate CAS 314771-76-1 Purity > 99.0% (HPLC) Hoobkas
Ruifu Chemical Supply Intermediates ntawm Afatinib
Afatinib CAS 439081-18-2
Afatinib Dimaleate CAS 850140-73-7
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
Tom ntej: Dimethylamino Acetaldehyde Diethyl Acetal CAS 3616-56-6
Tom ntej: Trans-4-Dimethylaminocrotonic Acid Hydrochloride CAS 848133-35-7
Diethylphosphonoacetic Acid CAS 3095-95-2
7-Fluoro-6-Nitroquinazolin-4(1H)-ib CAS 162012-69-3
7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2
N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1
(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-DiamineCAS Nr .: 314771-76-1
(S)-N-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-((Tetrahydrofuran-3-yl)oxy)quinazolin-4-AmineCAS Nr .: 314771-88-5
Tshuaj npe | (S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-Diamine |
Synonyms | N4-(3-Chloro-4-Fluorophenyl)-7-[[((3S)-Tetrahydro-3-Furanyl]oxy] -4,6-Quinazolinediamine;Afatinib impurity B;Afatinib-des (4-Dimethylamino-2-en-1-oxo) butyl;Des (4-Dimethylamino-2-en-1-oxo)butyl Afatinib |
CAS Nr | 314771-76-1 |
CAT Number | Tus Qauv Zauv: RF-PI2028 |
Tshuag xwm txheej | Hauv Tshuag, Muaj Peev Xwm Ntau Lawm 100MT / Xyoo |
Molecular Formula | C18H16ClFN4O2 |
Molecular Luj | 374.8 ib |
Boiling Point | 559.0 ± 50.0 ℃ |
Qhov ntom | 1.473 ± 0.060 g / cm3 |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Lub teeb daj rau daj hmoov |
Kev txheeb xyuas | Lub Sijhawm Tuav Pov Hwm ntawm Thawj Tswj Hwm Peak hauv HPLC yuav tsum ua raws li tus qauv |
Purity / Analysis Method | > 99.0% (HPLC) |
Poob rau ziab | <0.50% |
Residue ntawm Ignition | <0.20% |
Ib leeg Impurity | <0.50% |
Tag nrho cov impurities | <1.00% |
Heavy Metals (raws li Pb) | ≤ 20ppm |
Test Standard | Enterprise Standard |
Kev siv | Intermediate of Afatinib Dimaleate (CAS: 850140-73-7) |
Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo
(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-Diamine (CAS: 314771-76-1) yog ib qho nruab nrab ntawm Afatinib Dimaleate CAS: 850140-73-7 Nr.Afatinib yog lub thib ob tiam muaj zog thiab irreversible dual inhibitor ntawm lub epidermal loj hlob yam receptor (EGFR) thiab tib neeg epidermal loj hlob receptor 2 (HER2) tyrosine kinase, tsim los ntawm Boehringer Ingelheim, lub teb chaws Yelemees.Nws muaj peev xwm ntawm irreversibly inhibiting kev ua ntawm tyrosine kinase los ntawm kev mus rau Michael cov tshuaj tiv thaiv nrog thiol pawg ntawm cysteine ntawm txoj hauj lwm 797 ntawm EGFR.Muaj nuj nqi: 1. Zoo li Lapatinib thiab Neratinib, Afatinib yog ib qho protein kinase inhibitor uas tseem irreversibly inhibits human epidermal growth factor receptor 2 (Her2) thiab epidermal growth factor receptor (EGFR) kinases.2. Afatinib tsis yog tsuas yog tawm tsam kev hloov pauv ntawm EGFR tsom los ntawm thawj tiam TKIs zoo li erlotinib lossis gefitinib, tab sis kuj tawm tsam kev hloov pauv xws li T790M uas tsis nkag siab rau cov qauv kev kho no.Vim tias nws cov haujlwm ntxiv tawm tsam Her2, nws tau raug tshuaj xyuas mob qog noj ntshav nrog rau lwm yam EGFR thiab Her2 uas tau tsav cov qog noj ntshav.3. Afatinib yog ib yam tshuaj rau thawj kab kev kho mob ntawm cov neeg mob uas txawv hom metastatic (EGFR mutation positive) non-small cell lung carcinoma (NSCLC).Nws ua raws li qhov tsis tuaj yeem hloov pauv covalent inhibitor ntawm receptor tyrosine kinases epidermal growth factor receptor (EGFR) thiab erbB-2 (HER2).